Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC

Programming Language Designed to Construct Synthetic DNA

By BiotechDaily International staff writers
Posted on 24 Oct 2013
Image: An artist’s rendering shows DNA structures and a chemical reaction “program” on the screen. A “chemical computer” executes the molecular program (Photo courtesy of Yan Liang, L2XY2.com).
Image: An artist’s rendering shows DNA structures and a chemical reaction “program” on the screen. A “chemical computer” executes the molecular program (Photo courtesy of Yan Liang, L2XY2.com).
Image: An example of a chemical program. Here, A, B, and C are different chemical species (Photo courtesy of Yan Liang, L2XY2.com).
Image: An example of a chemical program. Here, A, B, and C are different chemical species (Photo courtesy of Yan Liang, L2XY2.com).
Chemists and biotech researchers may soon be able to use a structured series of instructions to “program” how DNA molecules interact in a test tube or cell, similar to using a programming language to write computer code.

A team of investigators, led by the University of Washington (UW; Seattle, USA), has developed a programming language for chemistry that it hopes will streamline efforts to design a network that can guide the behavior of chemical-reaction amalgams in the same manner that embedded electronic controllers guide robots, cars, and other devices. In medicine, such networks could serve as “smart” drug deliverers or disease detectors at the cellular level.

The study’s findings were published online September 29, 2013, in the journal Nature Nanotechnology. Chemists and educators teach and use chemical reaction networks, 100-year-old language of equations that describes how mixtures of chemicals behave. The UW engineers take this language an additional step and use it to write programs that direct the movement of customized molecules.

“We start from an abstract, mathematical description of a chemical system, and then use DNA to build the molecules that realize the desired dynamics,” said corresponding author Dr. Georg Seelig, a UW assistant professor of electrical engineering and of computer science and engineering. “The vision is that eventually, you can use this technology to build general-purpose tools.”

Currently, when a biologist or chemist makes a specific type of molecular network, the engineering process is complicated, cumbersome, and difficult to repurpose for constructing other systems. The UW engineers wanted to devise a framework that gives scientists more flexibility. Dr. Seelig compares this new approach to programming languages that tell a computer what to do. “I think this is appealing because it allows you to solve more than one problem,” he said. “If you want a computer to do something else, you just reprogram it. This project is very similar in that we can tell chemistry what to do.”

Humans and other organisms already have complex networks of nano-sized molecules that help to control cells and keep the body in line. Scientists now are finding ways to design synthetic systems that behave similar to biologic ones with the hope that synthetic molecules could support the body’s natural functions. To achieve this, a system is needed to create synthetic DNA molecules that vary according to their specific functions.

The new application is not yet ready to be utilized in medicine, but future uses could include using this framework to make molecules that self-assemble within cells and serve as “smart” sensors. These could be embedded in a cell, then programmed to identify abnormalities and respond as required, possibly by delivering drugs directly to those cells.

Drs. Seelig and colleague Eric Klavins, a UW associate professor of electrical engineering, recently received USD 2 million from the National Science Foundation (Washington DC, USA) as part of a national initiative to enhance research in molecular programming. The new language will be used to support that larger initiative, according to Dr. Seelig.

Related Links:

University of Washington



Channels

Genomics/Proteomics

view channel
Image: The photo shows a mouse pancreatic islet as seen by light microscopy. Beta cells can be recognized by the green insulin staining. Glucagon is labeled in red and the nuclei in blue (Photo courtesy of Wikimedia Commons).

Regenerative Potential Is a Trait of Mature Tissues, Not an Innate Feature of Newly Born Cells

Diabetes researchers have found that the ability of insulin-producing beta cells to replicate and respond to elevated glucose concentrations is absent in very young animals and does not appear until after weaning.... Read more

Drug Discovery

view channel
Image: Wafers like the one shown here are used to create “organ-on-a-chip” devices to model human tissue (Photo courtesy of Dr. Anurag Mathur, University of California, Berkeley).

Human Heart-on-a-Chip Cultures May Replace Animal Models for Drug Development and Safety Screening

Human heart cells growing in an easily monitored silicon chip culture system may one day replace animal-based model systems for drug development and safety screening. Drug discovery and development... Read more

Biochemistry

view channel
Image:  Model depiction of a novel cellular mechanism by which regulation of cryptochromes Cry1 and Cry2 enables coordination of a protective transcriptional response to DNA damage caused by genotoxic stress (Photo courtesy of the journal eLife, March 2015, Papp SJ, Huber AL, et al.).

Two Proteins Critical for Circadian Cycles Protect Cells from Mutations

Scientists have discovered that two proteins critical for maintaining healthy day-night cycles also have an unexpected role in DNA repair and protecting cells against genetic mutations that could lead... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.